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Background: Type 2 diabetes mellitus (T2DM) is associated with cognitive impairment and brain
abnormalities on MRI. The underlying mechanisms are unclear. We examined the relationship between
cerebral haemodynamics (cerebral blood ﬂow (CBF) and cerebrovascular reactivity (CVR)) and cognitive
performance and brain volumes in patients with T2DM, at baseline and after four years.
Methods: 114 patients with T2DM, aged 56–80 years, underwent a detailed cognitive assessment and MRI
scan. In 68 patients the evaluation was repeated after four years. CBF (two-dimensional ﬂow-encoded phase-
contrast MRI) and CVR (carbogen breathing response middle cerebral artery; transcranial Doppler) were
measured at baseline. Cognitive performance was expressed as composite z-score and regression based index
score. Brain volumes were measured on MRI by automated segmentation. The relationship of haemody-
namics with cognition and brain volumes was examined with linear regression analyses adjusted for age, sex
and IQ.
Results: Mean CVR was 51.8%±18.0% and mean rCBF 53.3±11.3 ml/min/100 ml brain tissue. CBF was
associated with baseline cognitive performance (standardized regression coefﬁcient β (95% CI): 0.17 (0.00;
0.32) and total brain volume (0.23 (0.05; 0.41)). No correlation was found between CVR and baseline
cognitive performance. Neither CBF nor CVR predicted change in cognition (CBF 0.11 (−0.21; 0.44); CVR 0.07
(−0.21; 0.36)) or total brain volume (CBF 0.09 (−0.22; 0.39); CVR 0.13 (−0.13; 0.40)) over four years.
Conclusions: CBF was associated with impaired cognition and total brain volume in cross-sectional analyses,
but did not predict changes in cognition or brain volumes over time. Apparently, alterations in cerebral
haemodynamics play no major etiological role in cognitive decline or change in brain volumes in non-
demented individuals with T2DM.
© 2012 Elsevier Inc. Open access under the Elsevier OA license. 1. Introduction
Type 2 diabetes mellitus (T2DM) is associated with cognitive
dysfunction and an increased risk of dementia (Biessels, Deary, &
Ryan, 2008). On brain MRI this is accompanied by modest atrophy
and a higher white matter hyperintensity (WMH) load (Biessels et
al., 2008; Manschot et al., 2007). We have previously reported that
T2DM-related cognitive changes and cerebral atrophy develop
slowly over the course of years, at an average rate that is still
within the range of that of normal aging (de Bresser et al., 2010; van
den Berg et al., 2010). Nevertheless, people with T2DM aretrecht, Department of Neurol-
GA Utrecht, The Netherlands.
ndel).
 OA license. overrepresented among those older individuals with accelerated
cognitive decline (Reijmer, van den Berg, Ruis, Kappelle, & Biessels,
2010). There is still uncertainty on the etiology, but vascular disease
is likely to play a role (Biessels et al., 2008). Indeed clinically
manifest atherosclerosis is associated with cognitive impairment in
people with T2DM (Bruce et al., 2008; Manschot et al., 2007).
Moreover, alterations in cerebral haemodynamics might affect the
brain, also in people without clinically manifest cerebrovascular
disease. In a cross-sectional study, we observed that cerebral blood
ﬂow (CBF) was related to cognition, but there were no differences in
CBF between controls and patients with T2DM (Tiehuis et al., 2008).
In the present longitudinal study, we further examined the
relationship between cerebral haemodynamics, as reﬂected by CBF
and cerebrovascular reactivity (CVR), and cognitive functioning and
brain volumes on MRI in patients with T2DM. This relationship was
assessed both at baseline and after four years of follow-up.
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2.1. Participants
Participants were included in the Utrecht Diabetic Encephalopathy
Study (UDES), a study on determinants of impaired cognition in
patients with T2DM. At baseline (2002–2004), 122 patients with
T2DM were recruited through their general practitioners. Further-
more, 56 age, sex and IQ matched controls were recruited among
spouses and acquaintances of the patients (Manschot et al., 2007). At
inclusion, all participants were between 56 and 80 years of age,
functionally independent and Dutch speaking. Diabetes duration had
to be at least one year. Exclusion criteria were a psychiatric or
neurological disorder (unrelated to diabetes) that could inﬂuence
cognitive functioning, a history of alcohol or substance abuse or
dementia, and a fasting blood glucose ≥7.0 mmol/l for control
participants. Participants with a history of transient ischaemic attacks
or non-disabling stroke could be included.
At follow-up four years later (2006–2008), seven participants had
died, four could not be contacted and 59 were not willing or able to
participate. Reasons for not participating were: lack of interest
(n=28); comorbidity (n=22; three reported dementia (two
patients, one control); and other reasons (n=9). One patient with
T2DM was excluded because of severe comorbid disease and one
control participant fulﬁlled the criteria for T2DM and was therefore
excluded from the control group. Hence, 106 subjects (68 patients
and 38 controls) participated in the follow up examination (van den
Berg et al., 2010). Baseline characteristics (demographics, cognitive
functioning and brain volumes) in participants (n=106) and non-
participants (n=70) at follow-up were similar (for details see (de
Bresser et al., 2010) and (van den Berg et al., 2010)). From 43 of the 70
non-participants at follow-up who were alive and could be contacted
a cognitive screening test was obtained by telephone (the Dutch
version of the Telephone Interview for Cognitive Status (Kempen,
Meier, Bouwens, van Deursen, & Verhey, 2007)). Mean performance
of non-participants (mean score 35.4±5.2) was similar to the
participants (36.5±4.6) at follow-up (van den Berg et al., 2010).
The present study only concerns those patients with T2DM from
whom baseline CBF or CVR data were available (n=114). Data from
the control group served as reference values.
The study was approved by the medical ethics committee of the
University Medical Center Utrecht and all participants signed an
informed consent form.
2.2. Haemodynamics
Both CBF and CVR were measured at baseline. For CBF measure-
ments a 2D-Phase Contrast MR section was positioned at the level of
the skull base to measure volume ﬂow in the internal carotid arteries
and basilar artery (TR 16 ms; TE 9 ms; ﬂip angle 7.5°; voxel size
0.98x0.98x5.00 mm3, averages 8; velocity sensitivity 100 cm/s) (Spilt
et al., 2002). Total CBF was deﬁned as the sum of ﬂow in both internal
carotid arteries and basilar artery. Because total CBF is related to brain
size, we calculated relative total CBF (rCBF), expressed as ml/min per
100 ml brain tissue (Appelman et al., 2008).
CVR was assessed with transcranial Doppler (TCD) as described
previously.(van Oers, Manschot, van Huffelen, Kappelle, & Biessels,
2006) CVR in response to a rise in CO2 was determined as the relative
change in blood ﬂow velocity in bothmiddle cerebral arteries after 1.5
min of carbogen inhalation. Left and right CVRs were averaged.
2.3. Neuropsychological examination
Neuropsychological examination consisted of 11 tasks, covering
5 cognitive domains (i.e. attention and executive functions,information processing speed, memory, abstract reasoning, and
visuoconstruction) (van den Berg et al., 2010). A division in these
cognitive domains was made a priori, according to standard
neuropsychological practise and cognitive theory (Lezak, Howieson,
& Loring, 2004). For the present study we used a composite z-score
of tests addressing the ﬁrst three domains, because these are
particularly sensitive to the effects of T2DM and vascular disease
(van den Berg et al., 2010). These domains were assessed with the
following tests: 1) attention and executive functions: Trail-making
Test (Part B), Stroop Color–Word Test (Part 3), Brixton Spatial
Anticipation Test, a letter ﬂuency test using the ‘N’ and ‘A’ and
category ﬂuency (animal naming); 2) information processing speed:
Trail-making Test (Part A), Stroop Color–Word Test (Part 1 and 2),
subtest Digit Symbol of the Wechsler Adult Intelligence Scale 3rd
edition (WAIS-3); 3) memory: forward and backward digit span of
the WAIS-3, Corsi Block-tapping Task, Rey Auditory Verbal Learning
Test, Location Learning Test, delayed trial of the modiﬁed Taylor
Complex Figure (Manschot et al., 2006).
Raw test scores at baseline and follow-up were standardized into
z-scores per test, by using the pooled mean of baseline scores of the
whole group. The z-scores of each domain were calculated by
averaging the test scores comprising that domain; these z-scores
were averaged to obtain one composite z-score. In secondary
analyses, each cognitive domain was addressed separately.
Change in cognitive performance over time was expressed as a
regression based index (RBI) score, using the control group as a
reference, taking age, sex and estimated IQ into account (Temkin,
Heaton, Grant, & Dikmen, 1999). A negative RBI score reﬂects
greater cognitive decline than expected from a control participant
with a similar demographic proﬁle and cognitive performance at
baseline. The RBI score is preferred over using change in z-scores
over time, because it reduces confounding by learning effects and
regression to the mean (Temkin et al., 1999). Mean change in
performance across the three domains was expressed as a
composite RBI score. In secondary analyses, the RBI score of each
cognitive domain was addressed separately. Pre-morbid IQ was
assessed by the Dutch version of the National Adult Reading test
(Manschot et al., 2006).2.4. Brain volume measurements
MRI scans were acquired on a 1.5 T Philips MR scanner using a
standardized protocol (38 contiguous slices, voxel size: 0.9 × 0.9 ×
4.0 mm3) and consisted of an axial T1 (repetition time in ms (TR)/
echo time in ms (TE): 234/2), T2 (TR/TE: 2200/100), proton
density (TR/TE: 2200/11), inversion recovery (IR) (TR/TE/inversion
time in ms (TI): 2919/22/410) and ﬂuid attenuated inversion
recovery (FLAIR) (TR/TE/TI: 6000/100/2000) (de Bresser et al.,
2010).
After registration of all sequences to the FLAIR image and an
inhomogeneity correction, a baseline brain mask was created by a k-
means clustering algorithm with 8 clusters for every patient using
all sequences. The baseline FLAIR image was rigidly registered to the
follow-up FLAIR image within patients. The resulting transform
parameters were applied to the baseline mask to create follow-up
masks. The uncorrected FLAIR images were multiplied voxelwise
times the mask images followed by an inhomogeneity correction.
The IR and FLAIR images were used for a k-nearest neighbour-based
probabilistic segmentation algorithm that measured total brain,
lateral ventricular and WMH volumes on both time points (Anbeek,
Vincken, van Bochove, van Osch, & van der Grond, 2005; de Bresser
et al., 2010). Volumes were expressed as percentage of total intra-
cranial volume to correct for between subject differences in head
size. Volume changes between baseline and follow-up scans were
calculated within participants.
207M. Brundel et al. / Journal of Diabetes and Its Complications 26 (2012) 205–2092.5. Markers of atherosclerosis
At baseline, carotid intima–media thickness (IMT) was measured
in both carotid arteries in a 1-cm trajectory proximal to the beginning
of the dilatation of the carotid bulb in 3 different longitudinal
projections. IMT was calculated as the mean of these 6 measurements
as described previously (Olijhoek et al., 2004).
A history of cardiovascular events was deﬁned as a clinical history
of myocardial infarction, stroke (not including TIA) or endovascular or
surgical treatment of carotid, coronal or peripheral arterial disease.2.6. Statistical analysis
Baseline WMH volume was multiplied by 100 and natural-log-
transformed because of non-normal distribution (Kolmogorov–
Smirnov, pb0.05). The relationship between baseline markers of
haemodynamics (rCBF, CVR) and baseline or change over time of
cognition and brain volumes was examined within the T2DM
group with linear regression analyses adjusted for age and sex
(cognition also for IQ). These relationships were expressed as
standardized betas.3. Results
Baseline characteristics of the patients with T2DM are presented in
Table 1. Mean CVR was 51.8%±18.0% and mean rCBF 53.3±11.3 ml/
min per 100 ml brain tissue (for the control participants: mean CVR
46.2%±16.6% and mean rCBF 57.7±12.2 ml/min per 100 ml brain
tissue). At baseline, the patient group with T2DM had a worse
cognitive performance than the control group (adjusted mean
difference in composite z-score between the T2DM and control
group (95% CI)−0.24 (−0.43;−0.05) (For details see (Manschot et
al., 2007)). Moreover, patients with T2DM had a signiﬁcantly smaller
relative total relative brain volume (−1.36% of intracranial volume
(−2.31; −0.40)) and larger lateral ventricular volume (0.37%
(−0.12; 0.87) andWMH volume (0.35 (−0.13; 0.83), WMH volumes
were multiplied by 100 and natural-log-transformed) (For details see
(de Bresser et al., 2010)).Table 1
Baseline characteristics.
Patients with type 2 diabetes (n=114)
Sex (men) 59 (52)
Age (years) 65.9±5.8
Estimated IQ 98±15
Diabetes duration (years) 8.7±6.1
HbA1c level (%) 6.8±1.1
Fasting glucose levels (mmol/l) 8.6±2.9
Use of insulin 32 (28)
Smoking (present or past) 78 (68)
Hypertension a 62 (54)
Hypercholesterolemia b 69 (61)








Total relative cerebral blood ﬂow
(ml/min per 100ml brain tissue) (n=85) d
53.3±11.3
Data shown are means±SD or n. Values in parenthesis are percentages.
a Deﬁned as a systolic blood pressure N160mmHg or a diastolic pressure N95mmHg
or use of antihypertensive drugs primarily for hypertension.
b Deﬁned as a fasting cholesterol N6.2 mmol/l or self reported use of lipid
lowering drugs.
c Deﬁned as history of a myocardial infarction, stroke (not including TIA) or
endovascular treatment of carotid, coronal or peripheral arterial disease.
d Deﬁned as the summed ﬂow in both carotid arteries and the basilar artery.Tables 2 and 3 show the associations of haemodynamics with
cognition and brain volumes. At baseline, lower rCBF was associated
with a lower composite z-score (β (95% CI): 0.17 (0.00; 0.32),
p=0.046). In secondary analyses on each cognitive domain sepa-
rately, lower rCBF was signiﬁcantly associated with the domains
attention and executive functioning (0.19 (0.02; 0.38), p=0.034) and
information processing speed (0.21 (0.01; 0.42), p=0.039). After
additional adjustment for a history of stroke, the association between
rCBF and composite z-score was attenuated (0.16 (0.00; 0.34),
p=0.053). In contrast, adjustment for C-IMT (0.17 (0.00; 0.33),
p=0.056), cardiovascular events (0.19 (0.02; 0.33), p=0.025) or
both (0.19 (0.02; 0.33), p=0.027) did not essentially change the
association. Lower rCBF was also signiﬁcantly associated with lower
baseline relative total brain volume (0.23 (0.05; 0.41, p=0.01).
Adjustment for C-IMT (0.24 (0.05; 0.42), p=0.01), cardiovascular
events (0.24 (0.07; 0.42) p=0.01), a clinical history of stroke (0.22
(0.05; 0.39), p=0.01) or all these factors (0.25 (0.06; 0.43) did not
change this association. Importantly, in the patients with T2DM who
also attended the follow up examination, the same relationship at
baseline between CBF and composite cognition (0.25 (0.02; 0.45) and
total relative brain volume (0.27 (-−0.02; 0.58) was found. It should
be noted that rCBF was expressed in ml/min per 100 ml brain tissue.
Hence, in patients with relatively lower brain volume, perfusion per
100 ml brain tissue was even less.
No signiﬁcant relationships between CVR and baseline composite
z-score, relative total relative brain volume, lateral ventricular volume
and WMH volume were observed.
Over four years, across the group of patients with T2DM cognitive
decline was not accelerated compared to the reference group
(composite score: RBI score±SD −0.06±0.73; mean change in z-
score±SD −0.11±0.24; for details see (van den Berg et al., 2010)).
Within the T2DM patient group neither baseline CVR, nor rCBF, was
signiﬁcantly related to cognitive decline over the 4 years of the study
(Table 2).
Over the four years, total relative brain volume decreased (change
over time (%)±SD: −1.46±0.71) and lateral ventricular
(0.36%±0.25%) and WMH volume increased (0.14%±0.18%) in the
patients with T2DM. Only the increase of lateral ventricular volume
was signiﬁcantly accelerated relative to controls (adjusted difference
between T2DM and control group (95% CI): 0.11% (0.00; 0.22)) (for
details see (de Bresser et al., 2010)). No signiﬁcant associations
between baseline rCBF or CVR and change of brain volumes over four
years were found (Table 3).4. Discussion
In this study sample of non-demented older patients with T2DM,
rCBF was associated with impaired cognition and total brain volume
in cross-sectional analyses. However, cerebral haemodynamics at
baseline appeared to be no predictor for changes in cognition or brain
volumes over time.
There is still uncertainty on the risk factors for cognitive decline
and brain abnormalities in T2DM. Previous studies, mostly cross-
sectional in design, point to chronic hyperglycaemia and microvas-
cular complications as well as atherosclerosis as relevant factors
(Biessels et al., 2008). A recent study found a relationship between
atherosclerosis (ankle–brachial index) and incident dementia after
six years in older patients with T2DM (Bruce et al., 2008). Likewise,
in the general population, atherosclerosis, also in blood vessels not
supplying the brain, is associated with cognitive impairments (de la
Torre, 2004; Hofman et al., 1997; Mathiesen et al., 2004). In previous
papers on the present study population, we reported that in patients
with T2DM a history of cardiovascular events was associated with
impaired information processing speed and memory, and more
severe vascular lesions on MRI (Manschot et al., 2007), but
Table 2
Relationship between baseline haemodynamics in patients with T2DM and cognition at baseline and change in cognition during follow-up.
Composite cognition Attention and executive functioning Information processing speed Memory
Baselinea
CVR (%) (n=96) 0.04 (−0.16; 0.25) 0.02 (−0.12; 0.16) 0.08 (−0.13; 0.30) −0.03 (−0.15; 0.10)
rCBF (ml min−1 100 ml−1) (n=85) 0.17 (0.00; 0.32) c 0.19 (0.02; 0.38) c 0.21 (0.01; 0.42) c −0.10 (−0.29; 0.10)
Longitudinal change b
CVR (%) (n=58) 0.07 (−0.21; 0.36) 0.17 (−0.10; 0.44) 0.03 (−0.22; 0.28) −0.16 (−0.43; 0.10)
rCBF (ml min−1 100 ml−1) (n=47) 0.11 (−0.21; 0.44) 0.16 (−0.16; 0.47) 0.01 (−0.19; 0.20) 0.00 (−0.48; 0.48)
Data are standardized regression Beta-coefﬁcients (95% CI), adjusted for age, sex and IQ.
CVR=cerebrovascular reactivity, rCBF=relative cerebral blood ﬂow.
a At baseline cognition is expressed as a (composite) z-score.
b The change in cognition over time is expressed as regression based index (RBI) score.
c pb0.05.
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years (van den Berg et al., 2010), or brain volume changes (de
Bresser et al., 2010).
The association between atherosclerosis and cognitive dysfunc-
tion and dementia might be mediated by alterations in cerebral
haemodynamics. However, inter-individual variation in haemody-
namics can obviously also reﬂect processes other than atheroscle-
rosis. Indeed, in the present study the relationship between rCBF
and cognitive dysfunction at baseline was independent of IMT and a
history of cardiovascular events. However, this association was not
independent of a clinical history of stroke. To the best of our
knowledge there are no other published studies on the relation
between cerebral haemodynamics and cognition in patients with
T2DM. In the general population, rCBF was found to be cross-
sectionally associated with cognitive functioning (especially infor-
mation processing speed and executive functioning). This associa-
tion was mediated by brain atrophy (Poels et al., 2008) and WMH
(Appelman, van der Graaf, Vincken, Mali, & Geerlings, 2010).
Furthermore, earlier cross-sectional studies found cerebral hypo-
perfusion to be associated with cognitive impairment and Alzhei-
mer's disease (Johnson et al., 2005).
Regarding the relationship between cerebral haemodynamics
and structural brain MRI markers, previous cross-sectional studies,
not speciﬁcally addressing T2DM, found reduced rCBF in non-
demented older individuals and older people with vascular risk
factors to be associated with WMH severity (Bastos-Leite et al.,
2008; van Es et al., 2010). However, previous studies on the relation
between rCBF and brain atrophy in elderly individuals with vascular
risk factors show conﬂicting results. While one study observed no
relationship between rCBF and atrophy (van Es et al., 2010),
another study found rCBF to be associated with subcortical atrophy
(Appelman et al., 2008). In patients with T2DM, a cross-sectional
relationship between lower regional rCBF and brain atrophy has
previously been reported (Last et al., 2007), in line with the cross-
sectional analyses in the present dataset.Table 3
Relationship between baseline haemodynamics in patients with T2DM and brain volumes
Total brain volume (%ICV)
Baseline
CVR (%) (n=96) −0.06 (−0.27; 0.13)
rCBF (ml min−1 100 ml−1) (n=85) 0.23 (0.05; 0.41) b
Longitudinal change
CVR (%) (n=58) 0.13 (−0.13; 0.40)
rCBF (ml min−1 100 ml−1) (n=47) 0.09 (−0.22; 0.39)
Data are standardized regression Beta-coefﬁcients (95% CI), adjusted for age and sex.
WMH=white matter hyperintensities, CVR=cerebrovascular reactivity, rCBF=relative ce
a Relative baseline WMH volumes were multiplied by 100 and natural-log-transformed.
b pb0.05.Remarkably, cerebral haemodynamics were unrelated to cognitive
decline and progression of atrophy in this sample. This does not
support a causal role for disturbed haemodynamics in cognitive
dysfunction and atrophy as might be inferred from the cross-sectional
studies. Reverse causality might even play a role. In other words, the
demand for CBF may be relatively lower in abnormal atrophic brain
tissue, thus giving rise to the observed associations in the cross-
sectional studies. This does not imply, however, that the impact of
T2DM on the brain is independent of vascular disease. In fact, white
matter hyperintensities and lacunar infarcts on brain MRI are more
common in patients with T2DM and these lesions are associated with
cognitive decline and brain atrophy (Sima, 2010). Moreover, recent
autopsy studies indicate that vascular brain damage is the key
neuropathological determinant of increased dementia risk in T2DM
(Ahtiluoto et al., 2010).
Strengths of the present study are the prospective design in
combination with detailed assessment of cognitive status and precise
brain volume measurements. A limitation is that the sample size was
modest. Nevertheless, point estimates for the regression coefﬁcients in
the longitudinal data were close to 0, with relatively narrow 95%
conﬁdence intervals, indicating that variation in haemodynamics could
explain, atmost, 5% of the variation (coefﬁcient of determination) in the
changes in cognition and brain volumes over four years, and that our
negative results are not due to lack of statistical power. Another
limitation could be the possible selective loss to follow-up. However,
participants and nonparticipants were comparable at baseline (de-
mographics, brain volumes) and follow-up (cognitive status) (de
Bresser et al., 2010; van den Berg et al., 2010). Finally, our global
measures of CBF and CVR may have missed regional abnormalities.
In summary, the present study showed that CBF was associated
with impaired cognition and total brain volume in cross-sectional
analyses but neither CBF, nor CVR predicted cognitive decline or
change of brain volumes over time. Apparently alterations in cerebral
haemodynamics play no major etiological role in cognitive decline or
change in brain volumes in non-demented individuals with T2DM.at baseline and change in brain volumes during follow up.
Lateral ventricular volume (%ICV) WMH volume a
0.20 (−0.03; 0.41) 0.05 (−0.19; 0.26)
−0.12 (−0.33; 0.11) −0.18 (−0.44; 0.00)
0.05 (−0.14; 0.19) 0.14 (−0.14; 0.56)
−0.08 (−0.53; 0.38) −0.23 (−0.62; 0.08)
rebral blood ﬂow, %ICV: percentage of intracranial volume.
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